Goldman Sachs
MACAW

Goldman Sachs’s Moringa Acquisition Corp Warrant MACAW Stock Holding History

Goldman Sachs’s Portfolio MACAW Stock Details MACAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-93,287
Closed -$6.44K – 6168
2024
Q2 		$6.44K Hold
93,287
– – ﹤0.01% 5560
2024
Q1 		$4.2K Hold
93,287
– – ﹤0.01% 5468
2023
Q4 		$1.81K Hold
93,287
– – ﹤0.01% 5559
2023
Q3 		$3.1K Hold
93,287
– – ﹤0.01% 5461
2023
Q2 		$7.01K Hold
93,287
– – ﹤0.01% 5615
2023
Q1 		$8.32K Hold
93,287
– – ﹤0.01% 5761
2022
Q4 		$8.96K Hold
93,287
– – ﹤0.01% 5759
2022
Q3 		$5K Hold
93,287
– – ﹤0.01% 6091
2022
Q2 		$10K Hold
93,287
– – ﹤0.01% 6268
2022
Q1 		$19K Hold
93,287
– – ﹤0.01% 6418
2021
Q4 		$52K Hold
93,287
– – ﹤0.01% 6260
2021
Q3 		$56K Hold
93,287
– – ﹤0.01% 6024
2021
Q2 		$71K Buy
+93,287
New +$59.2K ﹤0.01% 6025

Goldman Sachs's MACAW Position: Q3 2024 in Review

Goldman Sachs sold out of Moringa Acquisition Corp Warrant (MACAW) in Q3 2024, closing a stake of 93,287 shares — an estimated $6.44K sold.

Goldman Sachs first reported a position in MACAW in Q2 2021 and held it in 13 quarters. The position peaked at $71K in Q2 2021. 0 funds tracked by Wall St. Rank hold MACAW as of Q3 2024.

  • Goldman Sachs reported no remaining Moringa Acquisition Corp Warrant position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 93,287 Moringa Acquisition Corp Warrant shares in Q3 2024, an estimated $6.44K.
  • Goldman Sachs first reported a position in Moringa Acquisition Corp Warrant in Q2 2021 and held it in 13 quarters.
  • Goldman Sachs's Moringa Acquisition Corp Warrant position peaked at $71K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Moringa Acquisition Corp Warrant as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.